Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 16.21
-0.85 (-4.98%)
May 20, 2026, 12:05 PM CST
SHE:002082 Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 374.21M CNY in the quarter ending March 31, 2026, with 18.76% growth. This brings the company's revenue in the last twelve months to 1.18B, down -11.50% year-over-year. In the year 2025, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.12B, down -22.59%.
Revenue (ttm)
1.18B
Revenue Growth
-11.50%
P/S Ratio
8.87
Revenue / Employee
784.81K
Employees
1,499
Market Cap
10.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | -326.04M | -22.59% |
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition